Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors
Open Access
- 27 January 2005
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 12 (7) , 588-596
- https://doi.org/10.1038/sj.gt.3302462
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyNature Medicine, 2000
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialGene Therapy, 2000
- HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part II. Vector Systems and ApplicationsNeoplasia, 1999
- HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part I. HSV-1 Structure, Replication and PathogenesisNeoplasia, 1999
- Gene Transfer to the Nigrostriatal System by Hybrid Herpes Simplex Virus/Adeno-Associated Virus Amplicon VectorsHuman Gene Therapy, 1999
- Current Treatment Modalities for Brain TumorPublished by Springer Nature ,1998
- Therapeutic Efficiency and Safety of a Second-Generation Replication-Conditional HSV1 Vector for Brain Tumor Gene TherapyHuman Gene Therapy, 1997
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Histopathology, classification, and grading of gliomasGlia, 1995
- Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus MutantScience, 1991